{
    "clinical_study": {
        "@rank": "105789", 
        "arm_group": [
            {
                "arm_group_label": "Healthy volunteers", 
                "arm_group_type": "Other", 
                "description": "Healthy volunteers"
            }, 
            {
                "arm_group_label": "Mild renal impairment", 
                "arm_group_type": "Experimental", 
                "description": "patients with mild (>50 and \u226480 mL/min) renal impairment"
            }, 
            {
                "arm_group_label": "Moderate renal impairment", 
                "arm_group_type": "Experimental", 
                "description": "patients with moderate (\u226530 and \u226450 mL/min) renal impairment"
            }, 
            {
                "arm_group_label": "severe renal impairment", 
                "arm_group_type": "Experimental", 
                "description": "patients with severe (<30 mL/min) renal impairment"
            }
        ], 
        "brief_summary": {
            "textblock": "A study to evaluate the pharmacokinetics of CP-690,550 in subjects with mild, moderate or\n      severe renal impairment, who do not require hemodialysis, compared to healthy controls."
        }, 
        "brief_title": "Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Participants with normal renal function who had creatinine clearance greater than (>) 80 milliliter/minute (mL/min), received single oral dose of CP-690,550 tablet 10 milligram (mg) orally.", 
                            "title": "CP-690,550 (Normal Renal Function)"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Participants with mild renal insufficiency who had creatinine clearance >50 mL/min but less than or equal to (=<) 80 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Mild Renal Insufficiency)"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Participants with moderate renal insufficiency who had creatinine clearance >=30 mL/min but =<50 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Moderate Renal Insufficiency)"
                        }, 
                        {
                            "@group_id": "B4", 
                            "description": "Participants with severe renal insufficiency who had creatinine clearance <30 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Severe Renal Insufficiency)"
                        }, 
                        {
                            "@group_id": "B5", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "6"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "6"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "6"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "6"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@value": "24"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "9.7", 
                                                "@value": "50.8"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "2.8", 
                                                "@value": "61.2"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "11.1", 
                                                "@value": "53.5"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@spread": "14.6", 
                                                "@value": "59.0"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@spread": "10.7", 
                                                "@value": "56.1"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "11"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "13"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "96.77", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "194.69", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "groups_desc": "1 way Analysis of Variance (ANOVA) on natural log-transformed AUC(0-\u221e) analyzed using linear model with degrees of renal impairment(creatinine clearance[CLcr, discrete]) evaluated using blood samples collected at screening as fixed effect. Statistical Analysis System (SAS) mixed procedure (PROC MIXED) was used. Anti-log of adjusted mean difference (CP-690,550[mild renal insufficiency] - CP-690,550[normal renal function]), 90% confidence interval (CI) were taken to estimate mean ratio and 90% CI.", 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of adjusted geometric means", 
                                    "param_value": "137.26"
                                }, 
                                {
                                    "ci_lower_limit": "100.53", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "202.24", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "One way ANOVA on natural log-transformed AUC (0 - \u221e) were analyzed using linear model containing degrees of renal impairment (CLcr, discrete) calculated using blood samples collected at screening as fixed effects. SAS procedure PROC MIXED was used for analysis. Anti-log of the adjusted mean difference (CP-690,550 [moderate renal insufficiency] - CP-690,550 [normal renal function]) and its corresponding 90% CI were taken to estimate the mean ratio and corresponding 90% CI.", 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of adjusted geometric means", 
                                    "param_value": "142.59"
                                }, 
                                {
                                    "ci_lower_limit": "157.02", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "315.89", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O4"
                                        ]
                                    }, 
                                    "groups_desc": "One way ANOVA on natural log-transformed AUC (0 - \u221e) were analyzed using linear model containing degrees of renal impairment (CLcr, discrete) calculated using blood samples collected at screening as fixed effects. SAS procedure PROC MIXED was used for analysis. Anti-log of the adjusted mean difference (CP-690,550 [severe renal insufficiency] - CP-690,550 [normal renal function]) and its corresponding 90% CI were taken to estimate the mean ratio and corresponding 90% CI.", 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of adjusted geometric means", 
                                    "param_value": "222.71"
                                }
                            ]
                        }, 
                        "description": "AUC (0 - \u221e) = Area under the plasma concentration versus time curve (AUC) from time zero (pre-dose) to extrapolated infinite time (0 - \u221e). It is obtained from AUC (0 - t) plus AUC (t - \u221e).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with normal renal function who had creatinine clearance greater than (>) 80 milliliter/minute (mL/min), received single oral dose of CP-690,550 tablet 10 milligram (mg) orally.", 
                                    "title": "CP-690,550 (Normal Renal Function)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants with mild renal insufficiency who had creatinine clearance >50 mL/min but less than or equal to (=<) 80 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Mild Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Participants with moderate renal insufficiency who had creatinine clearance >=30 mL/min but =<50 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Moderate Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Participants with severe renal insufficiency who had creatinine clearance <30 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Severe Renal Insufficiency)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "71.5", 
                                                        "@value": "268"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "109", 
                                                        "@value": "370"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "154", 
                                                        "@value": "396"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "214", 
                                                        "@value": "615"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "AUC (0 - \u221e) = Area under the plasma concentration versus time curve (AUC) from time zero (pre-dose) to extrapolated infinite time (0 - \u221e). It is obtained from AUC (0 - t) plus AUC (t - \u221e).", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Area Under the Curve From Time Zero to Extrapolated Infinite Time [AUC (0 - \u221e)]", 
                                    "units": "nanogram*hour/milliliter (ng*hr/mL)"
                                }
                            ]
                        }, 
                        "population": "Analysis set included all participants who received study medication.", 
                        "safety_issue": "No", 
                        "time_frame": "0 (Pre-dose), 0.5, 1, 1.5, 2, 4, 8, 10, 12, 16, 24, 48 hours post-dose", 
                        "title": "Area Under the Curve From Time Zero to Extrapolated Infinite Time [AUC (0 - \u221e)]", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "67.22", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "129.06", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "groups_desc": "One way ANOVA on natural log-transformed Cmax were analyzed using linear model containing degrees of renal impairment (CLcr, discrete) calculated using blood samples collected at screening as fixed effects. SAS procedure PROC MIXED was used for analysis. Anti-log of the adjusted mean difference (CP-690,550 [mild renal insufficiency] - CP-690,550 [normal renal function]) and its corresponding 90% CI were taken to estimate the mean ratio and corresponding 90% CI.", 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of adjusted geometric mean", 
                                    "param_value": "93.15"
                                }, 
                                {
                                    "ci_lower_limit": "75.18", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "144.34", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "groups_desc": "One way ANOVA on natural log-transformed Cmax were analyzed using linear model containing degrees of renal impairment (CLcr, discrete) calculated using blood samples collected at screening as fixed effects. SAS procedure PROC MIXED was used for analysis. Anti-log of the adjusted mean difference (CP-690,550 [moderate renal insufficiency] - CP-690,550 [normal renal function]) and its corresponding 90% CI were taken to estimate the mean ratio and corresponding 90% CI.", 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of adjusted geometric mean", 
                                    "param_value": "104.17"
                                }, 
                                {
                                    "ci_lower_limit": "84.91", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "163.02", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O4"
                                        ]
                                    }, 
                                    "groups_desc": "One way ANOVA on natural log-transformed Cmax were analyzed using linear model containing degrees of renal impairment (CLcr, discrete) calculated using blood samples collected at screening as fixed effects. SAS procedure PROC MIXED was used for analysis. Anti-log of the adjusted mean difference (CP-690,550 [severe renal insufficiency] - CP-690,550 [normal renal function]) and its corresponding 90% CI were taken to estimate the mean ratio and corresponding 90% CI.", 
                                    "non_inferiority": "No", 
                                    "param_type": "Ratio of adjusted geometric mean", 
                                    "param_value": "117.65"
                                }
                            ]
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with normal renal function who had creatinine clearance greater than (>) 80 milliliter/minute (mL/min), received single oral dose of CP-690,550 tablet 10 milligram (mg) orally.", 
                                    "title": "CP-690,550 (Normal Renal Function)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants with mild renal insufficiency who had creatinine clearance >50 mL/min but less than or equal to (=<) 80 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Mild Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Participants with moderate renal insufficiency who had creatinine clearance >=30 mL/min but =<50 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Moderate Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Participants with severe renal insufficiency who had creatinine clearance <30 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Severe Renal Insufficiency)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "25.3", 
                                                        "@value": "94.2"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "23.2", 
                                                        "@value": "87.3"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "47.5", 
                                                        "@value": "104"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "28.6", 
                                                        "@value": "111"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Maximum Observed Plasma Concentration (Cmax)", 
                                    "units": "ng/mL"
                                }
                            ]
                        }, 
                        "population": "Analysis set included all participants who received study medication.", 
                        "safety_issue": "No", 
                        "time_frame": "0 (Pre-dose), 0.5, 1, 1.5, 2, 4, 8, 10, 12, 16, 24, 48 hours post-dose", 
                        "title": "Maximum Observed Plasma Concentration (Cmax)", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with normal renal function who had creatinine clearance greater than (>) 80 milliliter/minute (mL/min), received single oral dose of CP-690,550 tablet 10 milligram (mg) orally.", 
                                    "title": "CP-690,550 (Normal Renal Function)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants with mild renal insufficiency who had creatinine clearance >50 mL/min but less than or equal to (=<) 80 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Mild Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Participants with moderate renal insufficiency who had creatinine clearance >=30 mL/min but =<50 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Moderate Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Participants with severe renal insufficiency who had creatinine clearance <30 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Severe Renal Insufficiency)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.50", 
                                                        "@upper_limit": "1.50", 
                                                        "@value": "0.75"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.50", 
                                                        "@upper_limit": "1.50", 
                                                        "@value": "1.00"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "0.50", 
                                                        "@upper_limit": "2.00", 
                                                        "@value": "0.75"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "0.50", 
                                                        "@upper_limit": "1.50", 
                                                        "@value": "0.75"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Time to Reach Maximum Observed Plasma Concentration (Tmax)", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Analysis set included all participants who received study medication.", 
                        "safety_issue": "No", 
                        "time_frame": "0 (Pre-dose), 0.5, 1, 1.5, 2, 4, 8, 10, 12, 16, 24, 48 hours post-dose", 
                        "title": "Time to Reach Maximum Observed Plasma Concentration (Tmax)", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Plasma decay half-life is the time measured for the plasma concentration to decrease by one half.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with normal renal function who had creatinine clearance greater than (>) 80 milliliter/minute (mL/min), received single oral dose of CP-690,550 tablet 10 milligram (mg) orally.", 
                                    "title": "CP-690,550 (Normal Renal Function)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants with mild renal insufficiency who had creatinine clearance >50 mL/min but less than or equal to (=<) 80 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Mild Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Participants with moderate renal insufficiency who had creatinine clearance >=30 mL/min but =<50 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Moderate Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Participants with severe renal insufficiency who had creatinine clearance <30 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Severe Renal Insufficiency)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.363", 
                                                        "@value": "2.37"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.857", 
                                                        "@value": "2.83"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.653", 
                                                        "@value": "2.88"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "0.480", 
                                                        "@value": "3.77"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Plasma decay half-life is the time measured for the plasma concentration to decrease by one half.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Plasma Decay Half-Life (t1/2)", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Analysis set included all participants who received study medication.", 
                        "safety_issue": "No", 
                        "time_frame": "0 (Pre-dose), 0.5, 1, 1.5, 2, 4, 8, 10, 12, 16, 24, 48 hours post-dose", 
                        "title": "Plasma Decay Half-Life (t1/2)", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Renal clearance is the volume of plasma from which the drug is completely removed by the kidney in a given amount of time.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with normal renal function who had creatinine clearance greater than (>) 80 milliliter/minute (mL/min), received single oral dose of CP-690,550 tablet 10 milligram (mg) orally.", 
                                    "title": "CP-690,550 (Normal Renal Function)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants with mild renal insufficiency who had creatinine clearance >50 mL/min but less than or equal to (=<) 80 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Mild Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Participants with moderate renal insufficiency who had creatinine clearance >=30 mL/min but =<50 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Moderate Renal Insufficiency)"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Participants with severe renal insufficiency who had creatinine clearance <30 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                                    "title": "CP-690,550 (Severe Renal Insufficiency)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "16.2", 
                                                        "@value": "113"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "28.7", 
                                                        "@value": "84.7"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "15.9", 
                                                        "@value": "27.4"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "7.52", 
                                                        "@value": "19.9"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Renal clearance is the volume of plasma from which the drug is completely removed by the kidney in a given amount of time.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Renal Clearance (CL R)", 
                                    "units": "mL/min"
                                }
                            ]
                        }, 
                        "population": "Analysis set included all participants who received study medication.", 
                        "safety_issue": "No", 
                        "time_frame": "0 (Pre-dose) to 12 hours post-dose, 12 to 24 hours post-dose", 
                        "title": "Renal Clearance (CL R)", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Participants with normal renal function who had creatinine clearance greater than (>) 80 milliliter/minute (mL/min), received single oral dose of CP-690,550 tablet 10 milligram (mg) orally.", 
                            "title": "CP-690,550 (Normal Renal Function)"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Participants with mild renal insufficiency who had creatinine clearance >50 mL/min but less than or equal to (=<) 80 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Mild Renal Insufficiency)"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "Participants with moderate renal insufficiency who had creatinine clearance >=30 mL/min but =<50 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Moderate Renal Insufficiency)"
                        }, 
                        {
                            "@group_id": "P4", 
                            "description": "Participants with severe renal insufficiency who had creatinine clearance <30 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Severe Renal Insufficiency)"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "6", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "6", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "ClinicalTrials.gov_Inquiries@pfizer.com", 
                "name_or_title": "Pfizer ClinicalTrials.gov Call Center", 
                "organization": "Pfizer, Inc.", 
                "phone": "1-800-718-1021"
            }, 
            "reported_events": {
                "desc": "The same event may appear as both an AE and a SAE. However, what is presented are distinct events. An event may be categorized as serious in one subject and as nonserious in another subject, or one subject may have experienced both a serious and nonserious event during the study.", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Participants with normal renal function who had creatinine clearance greater than (>) 80 milliliter/minute (mL/min), received single oral dose of CP-690,550 tablet 10 milligram (mg) orally.", 
                            "title": "CP-690,550 (Normal Renal Function)"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Participants with mild renal insufficiency who had creatinine clearance >50 mL/min but less than or equal to (=<) 80 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Mild Renal Insufficiency)"
                        }, 
                        {
                            "@group_id": "E3", 
                            "description": "Participants with moderate renal insufficiency who had creatinine clearance >=30 mL/min but =<50 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Moderate Renal Insufficiency)"
                        }, 
                        {
                            "@group_id": "E4", 
                            "description": "Participants with severe renal insufficiency who had creatinine clearance <30 mL/min, received single oral dose of CP-690,550 tablet 10 mg orally.", 
                            "title": "CP-690,550 (Severe Renal Insufficiency)"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "6"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "6"
                                            }
                                        ], 
                                        "sub_title": "Hypertension"
                                    }
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }
                                        ], 
                                        "sub_title": "Tooth disorder"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }
                                        ], 
                                        "sub_title": "Respiratory tract infection"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "COSTART", 
                    "frequency_threshold": "0"
                }
            }
        }, 
        "completion_date": {
            "#text": "March 2004", 
            "@type": "Actual"
        }, 
        "condition": "Renal Impairment", 
        "condition_browse": {
            "mesh_term": "Renal Insufficiency"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects with normal renal function: Subjects must be healthy with estimated\n             creatinine clearance >80 mL/min\n\n          -  Subjects with renal impairment: Subjects should be in good general health\n             commensurate with the population with chronic kidney disease\n\n        Exclusion Criteria:\n\n          -  Kidney transplant patients\n\n          -  Subjects with any condition possibly affecting drug absorption\n\n          -  Subjects with malignancies with the exception of adequately treated basal cell\n             carcinoma of the skin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 16, 2012", 
        "firstreceived_results_date": "December 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01740362", 
            "org_study_id": "A3921006"
        }, 
        "intervention": [
            {
                "arm_group_label": "Healthy volunteers", 
                "description": "10 mg (2 x 5 mg tablets), single dose", 
                "intervention_name": "CP-690,550", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Mild renal impairment", 
                "description": "10 mg (2 x 5 mg tablets), single dose", 
                "intervention_name": "CP-690,550", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Moderate renal impairment", 
                "description": "10 mg (2 x 5 mg tablets), single dose", 
                "intervention_name": "CP-690,550", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "severe renal impairment", 
                "description": "10 mg (2 x 5 mg tablets), single dose", 
                "intervention_name": "CP-690,550", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "CP-690", 
            "550", 
            "pharmacokinetics", 
            "renal impairment"
        ], 
        "lastchanged_date": "December 3, 2012", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3921006&StudyName=Pharmacokinetics%20Of%20CP-690%2C550%20In%20Patients%20With%20Impaired%20Renal%20Function%20"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70118"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70119"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55404"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Phase 1, Open-Label Study To Evaluate Single Dose Pharmacokinetics, Safety And Tolerability Of CP-690,550 In Patients With Impaired Renal Function", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2004", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "AUC (0 - \u221e) = Area under the plasma concentration versus time curve (AUC) from time zero (pre-dose) to extrapolated infinite time (0 - \u221e). It is obtained from AUC (0 - t) plus AUC (t - \u221e).", 
                "measure": "Area Under the Curve From Time Zero to Extrapolated Infinite Time [AUC (0 - \u221e)]", 
                "safety_issue": "No", 
                "time_frame": "0 (Pre-dose), 0.5, 1, 1.5, 2, 4, 8, 10, 12, 16, 24, 48 hours post-dose"
            }, 
            {
                "measure": "Maximum Observed Plasma Concentration (Cmax)", 
                "safety_issue": "No", 
                "time_frame": "0 (Pre-dose), 0.5, 1, 1.5, 2, 4, 8, 10, 12, 16, 24, 48 hours post-dose"
            }, 
            {
                "measure": "Time to Reach Maximum Observed Plasma Concentration (Tmax)", 
                "safety_issue": "No", 
                "time_frame": "0 (Pre-dose), 0.5, 1, 1.5, 2, 4, 8, 10, 12, 16, 24, 48 hours post-dose"
            }, 
            {
                "description": "Plasma decay half-life is the time measured for the plasma concentration to decrease by one half.", 
                "measure": "Plasma Decay Half-Life (t1/2)", 
                "safety_issue": "No", 
                "time_frame": "0 (Pre-dose), 0.5, 1, 1.5, 2, 4, 8, 10, 12, 16, 24, 48 hours post-dose"
            }, 
            {
                "description": "Renal clearance is the volume of plasma from which the drug is completely removed by the kidney in a given amount of time.", 
                "measure": "Renal Clearance (CL R)", 
                "safety_issue": "No", 
                "time_frame": "0 (Pre-dose) to 12 hours post-dose, 12 to 24 hours post-dose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01740362"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2003", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}